CIRS - Centre for Innovation in Regulatory Science

CIRS - Centre for Innovation in Regulatory Science is a UK-based subsidiary of Clarivate plc. CIRS provides a platform for industry, regulators, HTA, and other healthcare stakeholders to collaborate on regulatory and reimbursement policies through innovative regulatory science. Founded in 2005, CIRS aims to facilitate access to pharmaceutical products and align global value-based decision making. It is governed and operated by Clarivate for the sole support of its members' activities. The organization has its own dedicated management and advisory boards, and its funding is derived from membership dues, related activities, special projects, and grants.

CIRS operates in the biotechnology industry and is headquartered in the United Kingdom. Although there is no publicly disclosed information about their last investment or investors, CIRS continues to play a crucial role in shaping regulatory and access (HTA) policies and processes globally.